Indaptus Therapeutics, Inc. — Form 8-K/A
Filed September 4, 2026 · analyzed by the 8-K Agent
8-K/A
— Neutral
significance 28/100
What the filing says
Indaptus Therapeutics filed an amended 8-K/A on September 8, 2026, reporting entry into a material definitive agreement effective August 28, 2026 (Item 1.01). The specific counterparty, dollar amounts, terms, and business impact are not disclosed in this filing header metadata. The full agreement details would require review of the actual exhibit documents referenced but not provided in this summary.
Why this rating
Metadata-only filing; no concrete deal terms, amounts, or counterparties disclosed here. Impossible to assess materiality without exhibit review.
Extracted items
- 1.01 material agreement
- 9.01 exhibits
See more from September 4, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.